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Abstract 
 
The pig and especially the minipig are becoming increasingly used as a test animal both 
in pharmacological and toxicological testing of new compounds. The minipig is used 
because of its size, it is easy to handle and less test substrate is required. When using an 
animal species for testing it is of importance to know if the test animal’s posses the same 
abilities to metabolize drugs as humans. Some of the P450 enzymes have been 
characterized in the pig regarding substrate specificity, inhibition and regulation. The 
porcine enzymes CYP1A, CYP2A and CYP3A all metabolize the same test substrates as 
the human enzymes, whereas the enzymes CYP2B, CYP2D, and CYP2E in pig on the 
other hand seem to be different from the human enzymes concerning metabolism of the 
well know test substrates. Some of the porcine enzymes have been sequenced i.e. 
CYP1A, CYP2A, CYP2B, CYP2D, CYP2E and CYP3A and not surprisingly the porcine 
CYPs that metabolize the human test substrates are about 75% identical in cDNA 
sequences. 
What is needed is inhibitory antibodies against each of the porcine enzymes, in order to 
test whether a test compound is metabolized by one or the other enzyme. Until now 
chemical inhibitors have been used, but they are rarely 100% specific. Anti-human 
inhibitory antibodies have also been used, but they may not recognize the porcine enzyme 
and therefore will not inhibit the reaction. Antibodies for immunoblotting would also 
make it possible to estimate how much of the total P450 the individual enzymes 
comprise. From what is known about the porcine P450, it can be concluded that the pig 
seems to be a good test species if CYP1A, CYP2A or CYP3A are involved in the 
metabolism of the test compound, depending on the contribution of other enzymes in 
competing pathways. 
 
Keywords: Cytochrome P450, microsomes, liver, porcine, metabolism, substrates, 
inhibitors, inducers. 
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Introduction. 
The development of new drugs always involves preclinical screening, where the main 
pharmacokinetic, pharmacodynamic, and toxicological properties are studied. These 
preclinical investigations are based on both in vitro and in vivo models using various 
animal species. The pig and especially minipigs are increasingly being used in 
pharmaceutical and toxicological studies, thus their metabolism have been subjected to 
further research and have recently attracted considerably attention.  This 
biotransformation occurs mainly in the liver, but also the kidneys, skin, lungs, and 
intestine can be involved. The biotransformation is one of the most important factors that 
can affect the overall therapeutic and/or toxic response of a drug. It can lead to 
deactivation / detoxification and excretion of the drug, but also to bioactivation. 
The metabolism reactions are generally divided into two groups, phase-1 and phase-2 
reactions. Phase-1 reactions involve the monooxygenases such as cytochrome P450 
complex, and flavin containing monooxygenases (FMO). The cytochrome P450 complex 
consists of several subfamilies with overlapping but different substrate specificities, 
different inhibitors and inducers. Several of these subfamilies i.e. CYP1A, CYP2A, 
CYP2B, CYP2C, CYP2E and CYP3A have been characterized for the pig and minipig 
(micropig) during the past few years using primary hepatocyte cultures or hepatocyte 
microsomes [1, 2, 3, 4, 5, 6, 7, 8, 9]. The characterization is done in order to enable the 
evaluation of the pig as a test animal for human drug metabolism. It is of importance to 
know if it is possible to extrapolate the result found in pigs to humans. The aim of this  
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paper is therefore to review what is known about the porcine P450 enzymes and compare 
this with their human counterparts. 
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Total P450 
The total cytochrome P450 activity in liver microsomes has been estimated for both 
conventional and Göttingen minipigs. The minipigs contained the highest activity of total 
P450 (0.81 nmol/prot) and the different strains of conventional pigs contained 0.57 
nmol/mg prot. [9], 0,22 nmol/mg prot [8], and 0.46 nmol/mg, respectively [5]. This 
shows that the conventional pigs have a P450 activity comparable to the total human 
P450 of 0.43nmol/mg protein and 0.26 nmol/mg protein in Caucasian and Japanese, 
respectively [10], whereas the minipigs total P450 is about 2 - 3 fold higher. 
 
CYP1A 
The CYP1A enzymes are involved in the metabolism of several carcinogens such as 
aromatic and heterocyclic amines, estrogens, mycotoxins and xanthines. These enzymes 
are also involved in the metabolism of several antidepressant and analgesic drugs. Human 
CYP1A activity is also present in porcine liver microsomes i.e. ethoxy- and methoxy-
resorufin O-dealkylation (EROD and MROD) [9]. The O-dealkylation of 7- 
ethoxyresorufin was found to be sex related in minipigs but not in conventional pigs [5]. 
The activity in female minipigs was 2-4 times higher than in male, whereas the opposite 
was found for human Caucasians [10, 4] where activity in females was 3 times lower than 
in males. The O-dealkylation ranged from 20 – 120 pmol/ mg/min in minipigs and the 
activities for the different conventional strains were 40 and 100 pmol/mg prot./min at a 
substrate concentration of  5 µM  [5, 9].  In one study the Vmax for EROD activity was 
found for both humans and micropigs. The human activities were 25 and 95 
 6
pmol/min/mg prot. for females and males respectively and the porcines were in the same 
scale 57 and 116 pmol/min/mg prot respectively for male and female pigs [4].  The 
porcine apoprotein level estimated by Western blotting using anti-human antibodies 
correlated well with enzyme activity (r2=0.72) [5], and so did the human activities and 
apoprotein level (r2=0.83) [10], indicating that CYP1A is the main responsible enzyme 
for this reaction. This was confirmed by inhibition tests both with a chemical inhibitor, α-
napthoflavone, a known inhibitor of CYP1A, and with antibodies against human 
CYP1A2 [11, 4]. Incubation with 1µM α-napthoflavone inhibited the CYP1A activity 
80-100% in humans and 60-80% in minipigs, whereas the antibody inhibited the reaction 
with only 30-60% in minipigs, probably due to a decreased specificity because of small 
differences in protein sequence. The CYP1A activity in pigs can also be increased by the 
same inducers as the human CYP1A. Lu and Li (2001) [12] compared the in vitro 
induction of CYP1A using omeprazole as inducer. They found omeprazole induction to 
be dose-dependent in both human and minipig hepatocytes, but the induction in human 
hepatocytes was about 3 times more potent than in minipigs.  Also β-napthoflavone 
(BNF) has been found to be a potent inducer of EROD and a less potent inducer of 
MROD activity in primary porcine hepatocytes both after 2, 4 and 8 days in culture [2, 
13]. The induction could be detected both at the apoprotein level and mRNA level, 
showing that the induction is transcriptional. Phenobarbital (PB) induction was studied in 
vivo and an increase in EROD activity and apoprotein level could be detected 24 hrs after 
ip injection of 80 mg/kg [3].     
 A porcine CYP1A1, but no CYP1A2 like cDNA (BAB85660.1) sequence, has been 
submitted to the GenBank. This cDNA encodes a protein that has about 75 % homology  
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to the human CYP1A1. These differences in amino acid sequence may cause the 
inhibition antibody to have a lower affinity toward this enzyme than to the human 
protein, resulting in a decrease in inhibition, or another enzyme could be involved in the 
metabolism. 
 
CYP2A 
The human CYP2A6 accounts for only 4% of the total P450 content and it metabolizes 
pharmaceuticals (3% of drugs metabolized) and compounds of toxicological significance, 
such as nicotine, nitrosamines and aflatoxin BI. In all studies the porcine CYP2A activity 
was determined using coumarin as test substrate. As in humans it is found to be the most 
specific substrate [15]. A sex dependent activity was seen for the coumarin 7-hydroxylase 
activities in minipig. Göttingen minipig especially showed marked differences, the male 
having 70 fold lower activity than females (0.005 nmol/mg protein, 0.35 nmol/mg 
protein) [5]. The Yucatan minipigs showed a 5 fold difference (0.18nmol/mg protein, 
0.97nmol/mg protein) [4], whereas human males metabolized coumarin 5 times faster 
than females, 1.3 nmol/mg prot/min and 0.36 nmol/mg prot./min, respectively [4]. These 
results also show that humans metabolized coumarin faster than pigs. This was in 
agreement with results published by Anzenbacher et al, 1998 [1], showing a 5 times 
higher metabolism in humans than in male minipigs. The metabolism rate for 
conventional pigs was found to be about 0.33 nmol/mg prot./min [5],  which is in 
between the values found for male and female minipigs. This is comparable with the 
published human values varying from 0 to 4.75 nmol/mg prot./min [14]. The apoprotein 
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level in both humans and pigs correlate well with the coumarin -7-hydroxylase activity 
indicating that the CYP2A is the main responsible enzyme for this activity [10, 14]. This 
is confirmed by inhibition studies, using both inhibitory antibodies against human 
CYP2A6 and chemical inhibitors. Bogaards et al. 2000 [4] found an inhibition of 60-80% 
in minipig and 80-100% in humans. Another study reported an inhibition of about 90% 
for both minipigs and conventional pigs [15]. Nicotine, a substrate for human CYP2A 
[16], was also tested as substrate for porcine CYP2A and the cotinine formation rate 
varied from 212-921 pmol/mg prot/min at a substrate concentration of 500 µM, well 
above the Km compared to the human mean Vmax value of 466 pmol/mg prot/min with 
values ranging from 70-2000 pmol/mg prot/min [15]. A positive correlation between 
cotinine formation and CYP2A protein level was found, but the addition of inhibitory 
antibody only inhibits the reaction with 40-60%, showing that cotine formation is not as 
specific a porcine CYP2A reaction as coumarin-7-hydroxylation. The activity of CYP2A 
could also be inhibited by methoxypsoralen, a known but not specific inhibitor of CYP2A 
activity [11]. 
The porcine CYP2A could not be induced in vitro by pyrazole, a known  inducer of 
murine CYP2A, and the activity  and apoprotein level of the enzyme decreases rapidly in 
porcine hepatocyte cultures and it is nearly absent after 48 h. [6]. From in vivo studies, 
using sexually mature male Göttingen minipigs, it could be seen that castration of the 
males induce the CYP2A activity of liver microsomes by about 10 times, which proves 
that the activity of this gene is sexually regulated in minipigs [17]. Positive correlations 
were found both between enzyme activity, apoprotein level and mRNA, suggesting a 
transcriptional regulation of the gene. Minipig (Göttingen) and conventional CYP2A 
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cDNA sequences have been submitted to the GenBank (accession nr. AY380866 and 
AB052255 respectively). The wild-type minipig and conventional cDNA sequences 
encodes proteins that are 99% homologous and these porcine proteins are 75% 
homologous to the human sequence (accession nr. NP0007379). Six substrate recognition 
sites (SRS) have been identified [18] and they were all found in the porcine proteins [15]. 
 
CYP2B 
The content of cytochrome CYP2B6 in humans is only about 1% of total P450, but the 
ability of CYP2B6 to metabolize a number of drugs (4%), such as diazepam, lidocaine 
and the antineoplastic compounds cyclophosphamide, iphosphamide, and tamoxifen, has 
attracted considerable attention to this enzyme [19]. Several of the human CYP2B test 
substrates have been used in order to measure the activity of this enzyme in pigs. The 
human model substrate is S-mephenytoin measuring the N-demethylation could not be 
detected in pigs [5]. The 7-ethoxy-4-triflouromethylcoumarin O-dealkylase activity, 
another CYP2B specific activity, was reported in Yucatan minipig. Females and males 
contained about the same activity (0.353 nmol/mg protein, 0.286 nmol/mg protein), and 
they were comparable with the human values [4]. The enzyme activity for both humans 
and pigs could be inhibited moderately (30-60%) with anti-rat CYP2B1. The low 
inhibition percentage may be because the antibody is not species specific or the substrate 
is only partly metabolized, by CYP2B. The 7-benzyloxyresorufin O-debenzylation has 
been measured in conventional porcine microsomes [8] and this activity is much higher 
in pigs than in humans, 370pmol/min/mg prot. compared to the  3.1 and 4.86 
pmol/min/mg prot reported by Amato et al and Niva et al. [20, 21].  
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Another CYP2B reaction, the 7-pentoxyresorufin  dealkylation  activity, could not be 
detected in pigs by some groups [1, 2, 5] but could be detected by other groups [3, 13], 
and this is properly due to differences in assay sensitivity. The activity is about the same 
in pigs as in humans (1-11 pmol/min/mg prot) [3, 22]. The reaction can be induced by 
phenobarbital, a known potent inducer of human CYP2B6, in vivo but not in vitro after 
24 hrs. incubation. The in vivo induction can be followed at both the activity, apoprotein 
and mRNA level [3], indicating that CYP2B catalyses or plays a significantly role in this 
reaction. Behnia et al 2003 [13 ] showed that the activity of CYP2B can also be induced 
in vitro by phenobarbital after 8 days in culture, but not after 4 days, where a decrease in 
activity was seen. The same applies to the benzyloxyresorufine O-dealkylase activity, 
another a CYP2B reaction. In the GenBank the porcine cDNA and protein sequence can 
be found for CYP2B22 (A B052256.1). The homology between this protein sequence  
and the human CYP2B6 is about 72%. These differences in protein sequence may play a 
role in the differences in substrate specificity between humans and pigs. 
 
 CYP2C 
The CYP2C subfamily consists of several enzymes. In humans, 4 different enzymes have 
been defined [23], CYP2C8, CYP2C9, CYP2C18 and CYP2C19 and all in all they 
constitute about 20% of total P450 and metabolizes 35% of drugs [24]. The CYP2C 
family metabolizes a range of drugs i.e. losartan, propofol, estrogens and testosterone, 
mephenotoin, and methadone [19]. The different CYP2C show some cross reactivity 
toward many of the test substrates, making it difficult to study the different CYP2C 
activities independently. The CYP2C substrates, tolbutamid and diclofenac, which are 
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fairly specific for human CYP2C9, have been tested in pigs. The tolbutamid 
hydroxylation has been measured in both conventional pigs and minipigs [8, 1] and it was 
shown that the minipigs had lower activity compared to human activity [1]. The activity 
was not  induced in pigs treated with a combination of  β-naphthoflavone, phenobarbital 
and dexamethasone [8], but the enzyme activity could  be inhibited by about 80% with 
tranylcypromine, a CYP2C19 inhibitor, whereas the activity was not inhibited by 
sulphaphenazole, an inhibitor of human CYP2C9 [11]. The diclofenac 4-hydroxylase 
activity was measured in Yucatan minipigs [4] and estimated to 0.06nmol/min/mg protein 
for males and 0.02nmol/mg/min for females; these activities were small compared to the 
human (1.5-1.9 nml/mg/min) values. This enzyme activity was inhibited 80-100% in 
humans by sulphaphenazole, as expected, but again the porcine activity was only slightly 
inhibited (20%), indicating that either the substrates or the inhibitor is not specific for this 
enzyme in  pigs, or the reaction is catalyzed by another enzyme. Mephenytoin 4-
hydroxylation was used as a test reaction for CYP2C19, but no enzyme reaction could be 
detected in neither conventional nor minipigs [8, 4, 5]. Immunoblotting, using anti-rat 
CYP2C11 that hybridize to human CYP2C19, did react with a porcine CYP2C protein 
and the highest protein level was found for the males. A porcine CYP2C49 cDNA and 
protein sequence has been submitted to GenBank (AB052258). This sequence shows 
about 70% homology to the 4 human CYP2C enzymes. 
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CYP2D 
 In humans, the CYP2D6 enzyme is one of the most important in drug metabolism. It 
comprises only 2% of the total P450 [10], but the enzyme metabolizes about 15% of all 
drugs [24], including antidepressants, antipsychotics, and β-blockers [19] and it shows 
high interindividual differences in humans due to polymorphisms. The capacity of 
CYP2D6 should therefore be measured in humans before medication, in order to avoid 
intoxication or adverse effects, but only few places does this routinely. The porcine 
CYP2D enzyme has been studied using different substrates and different antibodies 
giving rise to different results. Three different human test substrates for CYP2D6, 
debrisoquine, bufuralol and dextromethorphan, have been used to characterize the 
porcine CYP2D.  
It was shown that conventional and Göttingen minipigs did not possess debrisoquine 4-
hydroxylase activity, but could biotransform dextromethorphan to dextorphan and 
catalyze the 1-hydroxylation of bufuralol [7]. Bogaard et al [4] have studied the 
metabolism of bufuralol in Yucatan micropigs and humans and found that the Vmax for 
micropigs was about 4 times higher than Vmax for humans. No sex differences for 
neither the pigs nor humans were seen. Immunoblotting, with different antibodies, gave 
different results. Blotting with polyclonal antibodies gave rise to some very strong bands, 
whereas blotting with monoclonal antibodies gave no detectable band in one study [7], 
whereas in another study the same antibody gave rise to a band [8]. These differences 
could be due to differences in the stringency in the immunoblotting assay or differences 
in breeds of swine. The metabolism of bufuralol and dextromethorphan was correlated to 
the immunoblotting result for several different porcine enzymes and a good correlation 
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was seen between the enzyme activities and CYP2B protein level in both minipigs and 
conventional pigs [7]. This indicates that CYP2B and not CYP2D is the main enzyme 
responsible for these reactions. Inhibition of bufuralol hydroxylation with either the 
CYP2D inhibitory chemical quinidine or antibody was not possible, whereas the same 
chemical inhibitor and antibody inhibited the human reaction 60-100% [4]. This further 
indicates that the porcine CYP2D is not responsible for the reaction. On the other hand, 
inhibition with orphenadrine, a human inhibitor of CYP2B6, was successful and  
dextromethorphan O-demethylation and bufuralol 1-hydroxylation in porcine 
microsomes could be inhibited by 82 % [7]. In addition pilocarpine and resveratrol 
inhibitors of CYP2B in mouse and rat respectively, could also inhibit the reaction 70% 
and 40 %, which indicate that CYP2B is catalyzing this reaction. Further, induction 
studies performed with hepatocyte cultures incubated with phenobarbital, a CYP2B 
inducer, showed an increase in metabolism of dextromethorphan [2]. In pig liver, a 
microsomal CYP2D25 gene catalyzing the vitamin D3 25-hydroxylase activity has been 
found. The sequence of this enzyme reveals that it is a member of the CYP2D family 
[25], as it contains many characteristics of microsomal P450. Alignment of this protein 
sequence and the human CYP2D6 shows that they share 78% homology. This high 
degree of homology may cause the antibodies used in immunoblotting to hybridize to the 
vitamin D3 25-hydroxylase protein instead of the CYP2D6 protein. In addition to the 
vitamin activity, this porcine enzyme can also catalyze the hydroxylation of the drug 
tolterodine, which is another substrate for human CYP2D6, showing that this enzyme 
exhibits cross reactivity with human CYP2D6.  
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CYP2E 
The human CYP2E1  is of clinical relevance because it is inducible by alcohol and it 
catalyses  the metabolism  or bioactivation of many different compounds such as 
alcohols, ketones, anesthetics and nitrosamines and about 3% of drugs metabolized by 
P450 [24]. The enzyme only represents 7% of total human P450 
Chlorzoxazone is the most used human test substrate to estimate the activity of CYP2E1, 
both in vivo and in vitro [26], as CYP2E1 catalyses the 6-hydroxylation of 
chlorzoxazone. The chlorzoxazone 6- hydroxylase activity was measured in porcine 
microsomes and it was found to be sex related in two minipig strains [4, 5], the females 
possessing the highest activity. In conventional pigs and humans, however, no differences 
between the sexes were seen [5, 27]. The Göttingen minipig activity was higher (F: 6 
nmol/min/mg protein, M: 1,23 nmol/min/mg protein) [5] than the activity in Yucatan 
micropigs (F: 0.71 nmol/min/mg protein, M: 0.29 nmol/min/mg protein) [4] and Yucatan 
micropig results were lower than human activity  (F: 2.8 nmol/min/mg protein, M: 1.3 
nmol/min/mg protein) [4]. The apoprotein level and mRNA concentration of CYP2E was 
measured in both minipigs and conventional pigs and it showed that there was no 
correlation between the enzyme activity, mRNA level, and apoprotein concentration, 
indicating that the regulation of the gene expression could take place at all steps in the 
biosynthesis of the protein or that this substrate is not specific for the porcine CYP2E [5]. 
Inhibition studies with antibodies showed that human chlorzoxazone 6-hydroxylase 
activity could be moderately inhibited by anti-rat CYP2E1, whereas the minipig activity 
was not inhibited at all [4]. Further ketoconazole and troleandomycin (TAO), two  
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CYP3A inhibitors could inhibit the activity up to 70-80% [11, 4]. This also indicates that 
chlorzoxazone is not a specific CYP2E substrate in pigs, but could also be a CYP3A 
substrate. Inhibition studies using anti- human CYP2A6 antibodies (preliminary results 
from our laboratory still not published) showed that this antibody could inhibit both the 
chlorzoxazone hydroxylase, aniline hydroxylase and p-nitrophenol hydroxylase activities, 
all known human CYP2E1 test reactions and they are all activities found in porcine 
microsomes [9]. The reactions could be inhibited about 40%, indicating that also CYP2A 
plays a significant role in metabolizing these compounds. In vivo induction studies by 
Desille et al. [3] in pigs with phenobarbital, gave rise to a 5x increase in CYP2E mRNA 
level and an increase in apoprotein concentration, whereas the metabolism of 
chlorzoxazone was unchanged. This again shows that CYP2E is not the main enzyme 
responsible for the metabolism of this substrate. Another in vivo induction study, where 
minipigs were fed ethanol, an inducer of human CYP2E1, gave a significant induction of 
CYP2E protein level in castrated pigs. The cDNA sequence and protein sequence of 
porcine CYP2E has been submitted to GenBank (submission no. AB052259) by 
M.Kajima. Blast analysis reveals that there is a 75 % (371 /493 amino acids) homology 
between the human and porcine protein sequence. Depending on where the differences 
are, they can alter the substrate affinity, especially if they are located in the active site i.e. 
substrate binding site resulting in low affinity toward chlorzoxazone. 
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CYP3A 
In humans the CYP3A4 is the most important P450 enzyme comprising about 30% of 
total P450 and metabolizing about 36% [24]  of all drugs and it is therefore also the most 
studied porcine cytochrome. In addition to drugs, this enzyme also converts sex 
hormones, polycyclic aromatic hydrocarbons and pesticides. 
Several different human CYP3A4 test substrates have been used to estimate the activity 
of porcine CYP3A. The 6β-hydroxylation of testosterone, the most used reaction in 
humans to estimate the activity of CYP3A4 [26], has been measured in two minipig 
strains and conventional pigs. Yucatan micropigs had a higher enzyme activity than 
Göttingen minipigs and conventional pigs, 4.45 nmol/min/mg protein compared to 0.87 
nmol/min/mg protein compared to 0.45 nmol/min/mg respectively [4, 5]. These values 
compare well to the average testosterone 6-hydroxylase activity in humans of 1.69 
nmol/min/mg protein. The nifedipine oxidase has also been measured in conventional 
pigs and minipigs and the activity measured is about the same as the activity obtained in 
human microsomes average 0.88 and 2.1 nmol/min/mg prot for pigs [3, 5] and 1.72 
nmol/min/mg prot. in humans [22]. The nifedipine N-oxidation activity correlated well 
with the testosterone 6-hydroxylase, and these activities again correlated with the 
apoprotein level measured using anti-human CYP3A in the immune blotting assay [5]. 
This shows that CYP3A in pigs is the main enzyme responsible for the two reactions. 
Inhibition studies with ketoconazole, a strong inhibitor of human testosterone 
hydroxylase, confirms this as ketoconazole could inhibit the testosterone hydroxylation 
up to 80% and it was found to be just as potent in pigs as in humans [11,  
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4]. Minipig microsomal nifedipine oxidation could be inhibited with troleandomycin, 
another human CYP3A4 inhibitor. This inhibitor had a lower potency towards the 
minipig CYP3A than towards the human CYP3A4 [1], which could be due to differences 
in the amino acid sequence of the protein. The enzyme level and inducibility of the 
CYP3A enzyme has been studied in vitro in porcine hepatocytes by several groups. In 
contrast to CYP2A the CYP3A activity remained constant during the first 72 hrs. of 
incubation, and the activity could be induced by rifampicin 3-4 times [28, 6] , a potent 
inducer of CYP3A4 in human hepatocyte cultures [29]. Rifampicin also induces both the 
1- and 4- hydroxylation of midazolam, whereas dexamethasone, another inducer of 
human CYP3A4, could induce neither the testosterone hydroxylation nor the midazolam 
hydroxylation [2, 30, 12]. Phenobarbital, phenytoin, and carbamazepine were also able to 
induce hydroxylation of testosterone [1, 28]. Induction with phenobarbital showed that 
CYP3A could be enhanced both in vitro and in vivo and at both enzyme activity level, 
apoprotein level, and at mRNA level [3]. 
The porcine CYP3A gene has been isolated and three different groups have submitted 
sequences to the GenBank (accession no. AAD04628, BAD06180, All13316). They 
share 82-83 % homology with the human protein sequence (416-419/503 amino acid). 
This is a higher homology than appeared for the CYP2B22 and CYP2E, which is 
reflected in more similar substrate affinities. 
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Discussion 
The metabolism and toxicology of new compounds has to be tested and this is done using 
test animals. When choosing test animals, it is of importance to know if the cytochrome 
P450 complex of the test animal species resembles that of humans, especially if the 
compound is going to be used as a human drug. The pig has become an increasingly used 
test animal, both in pharmacology and toxicology, because it resembles humans in many 
ways. Therefore, it is of importance to characterize and compare the porcine P450 to the 
human P450, in order to be able to extrapolate the results from porcine experiment to 
humans. Total P450 activity was approximately the same for humans and pigs, depending 
on the strain of pigs, as the minipigs tend to have a higher total P450 activity than the 
conventional pigs [5]. Many of the reactions catalyzed by the human enzymes CYP1A2, 
CYP2A6 and CYP3A4 can also be measured in pigs and the enzyme activities correlate 
with the apoprotein level found in Western blotting using anti-human antibodies. The 
reactions could also be inhibited either with inhibitory antibodies or with chemical 
inhibitors for these enzymes, indicating that these porcine enzyme systems are very 
similar to the human enzymes. This is, however, not the case for the CYP2D and CYP2E. 
Most of the human test reactions for these enzymes can also be catalyzed by porcine liver 
microsomes, but the activity does not correlate with the same apoprotein level. The 
metabolism of the human CYP2D substrates, bufuralol and dextromethorphan, correlates 
with the protein level of a CYP2B like protein and can be inhibited by CYP2B inhibitors, 
suggesting that porcine CYP2B play an important role in catalyzing these reactions. The 
human test reactions for CYP2E did not correlate with CYP2E protein level, but could be 
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inhibited with anti-human CYP2A and with CYP3A chemical inhibitors, indicating that 
these two porcine enzyme systems catalyze these reactions. Chemical inhibition studies 
should be carefully evaluated, as most of the chemicals are not specific inhibitors towards 
one enzyme, but may also inhibit other enzymes, but less potent [30]. Small changes in 
protein sequence may also result in less potent or no inhibition and the same will apply 
for inhibitory antibodies, when they are raised against another species. Therefore, a 
negative result with inhibitory anti-human or anti-rat antibodies does not necessarily 
imply that the reaction is not catalyzed by the same enzyme in pigs.  
In vitro induction of CYP1A is very similar for human and porcine hepatocytes [12], 
whereas dexamethasone, a human model inducer of CYP3A4, could not induce porcine 
hepatocytes, in contrast to some of the other mode inducers. In vivo induction studies 
have also been performed using different inducers i.e. phenobarbital that was found to 
induce CYP1A, CYP2B, CYP2E and CYP3A measured at protein level [3]. Myers et al 
[8] also studied in vivo induction at protein level, using a cocktail containing β-
naphthoflavone, phenobarbital and dexamethaxone. Their induction results measured at 
protein level varied, depending on the antibodies used for immunoblotting. The drawback 
of these in vivo induction experiments is, however, that the control levels of the induced 
pigs are not known. This makes it more difficult to find significance in these studies, as 
the standard deviation is high because of big interindividual differences. A study looking 
at gender specific induction of CYP2A, however, has overcome this by hepatic resection. 
The resection makes it possible to measure the control level for the pigs used in the  
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experiment [22]. The same applies for inducers, as for inhibitors, they are very rarely 
specific towards one enzyme, but are able to induce several enzymes [28].  It is therefore 
of importance, when studying the induction at the protein level, to know the specificity of 
the antibodies used for immunoblotting and to use species specific antibodies, if 
available, or to use antibodies specific to species closely related. Looking at induction at 
the activity level is also difficult, because of the lack of total specificity towards the 
different substrates. If the induction is transcriptional, it can also be followed at the 
mRNA level. The induction of mRNA can, in contrast to activity and apoprotein 
induction, be measured specifically for each enzyme, if the cDNA sequence is known. 
This will give a more reliable (precise) measure for induction.  
Much work has yet to be done in order to fully characterize the porcine P450 enzymes. 
First of all, sequencing of the enzymes’ cDNA that have not yet been sequenced i.e. the 
different CYP2C, should be done. Then cloning of the sequenced genes and recombinant 
expression of each P450 enzymes will enable the testing of substrate specificity towards 
the proteins, one by one.  In order to deduce how many % of total P450 each enzyme 
account for, one must raise porcine specific immunoblotting antibodies against the 
different enzymes. Specific porcine inhibitory antibodies against the enzymes will also be 
needed to estimate how big a role each enzyme plays in the metabolism of different 
substrates in porcine microsomes. 
Evaluation of toxicity and metabolism of new drugs is based on animal test systems and 
the selection of an appropriate system is of paramount importance. Before testing it is 
important to try from e.g. QSAR (quantitative structure-activity relationship) analysis to 
decide which CYP(s) is expected to be involved and then decide on species for the testing 
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procedure. It can be concluded, from what is known at present about the porcine CYP 
enzymes, that the pig is a good test species, if CYP1A, CYP2A and CYP3A are involved 
in the metabolism of the compound to be tested.  
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